Treace James T. - 18 Jan 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor as Attorney-in-fact for James T. Treace
Issuer symbol
TMCI
Transactions as of
18 Jan 2022
Net transactions value
-$1,444,531
Form type
4
Filing time
20 Jan 2022, 17:08:46 UTC
Previous filing
30 Dec 2021
Next filing
14 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale $699,676 -36,144 -2.5% $19.36 1,425,297 18 Jan 2022 Direct F1, F2
transaction TMCI Common Stock Sale $135,893 -6,793 -0.48% $20.00 1,418,504 18 Jan 2022 Direct F1, F3
transaction TMCI Common Stock Sale $608,963 -32,063 -2.3% $18.99 1,386,441 19 Jan 2022 Direct F1, F4
holding TMCI Common Stock 1,006,183 18 Jan 2022 By spouse
holding TMCI Common Stock 2 18 Jan 2022 By J&A Group LLC F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.75 to $19.73 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.75 to $20.355 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.4550 to $19.40 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company.